Beyond the Lauren Classification: An Uncommon Case of Mixed Gastric Adenocarcinoma
DOI:
https://doi.org/10.22516/25007440.1426Keywords:
Gastric neoplasms, adenocarcinoma, stomach neoplasmsAbstract
Gastric cancer (GC) is a heterogeneous neoplasm with high mortality, particularly in countries such as Colombia. Among its variants, mixed gastric adenocarcinoma—combining intestinal and diffuse components—represents an infrequent but clinically aggressive form (6%–22%). An atypical case is presented involving an apparently benign gastric polyp, whose histopathological examination revealed a poorly differentiated (grade 3) mixed adenocarcinoma, classified as Borrmann type I. Cases of this nature underscore the importance of meticulous endoscopic and histological evaluation, even in lesions with an innocuous appearance, and highlight the need for rigorous surveillance in neoplasms with aggressive biological behavior.
Downloads
References
National Cancer Institute. Cancer stat facts: stomach cancer [Internet]. SEER [consultado el 20 agosto del 2025]. Disponible en: https://seer.cancer.gov/statfacts/html/stomach.html
Shah SC, Wang AY, Wallace MB, Hwang JH. AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review. Gastroenterology. 2025;168(2):405-416.e1. https://doi.org/10.1053/j.gastro.2024.11.001
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Colombia. Lyon, France: International Agency for Research on Cancer; 2024 [consultado el 20 agosto del 2025]. Disponible en: https://gco.iarc.who.int/media/globocan/factsheets/populations/170-colombia-fact-sheet.pdf
Oliveros Wilches R, Grillo-Ardila CF, Vallejo-Ortega M, Gil-Parada F, Cardona-Tobón M, Páramo-Hernández D, et al. Guía de práctica clínica para la prevención primaria y secundaria y diagnóstico temprano de cáncer gástrico. Rev Colomb Cancerol. 2022;26(1):39-96. https://doi.org/10.35509/01239015.754
Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69(5):823-829. https://doi.org/10.1136/gutjnl-2019-320234
Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HWM, Janjigian YY, et al. Gastric cancer. Lancet. 2025;405(10494):2087-2102. https://doi.org/10.1016/S0140-6736(25)00052-2
Qu X, Zhao X, Liu Y, Wang N, Zhang L, Zhu X, et al. The clinicopathological characteristics of early-onset gastric cancer and its evolutionary trends: a retrospective study. Am J Cancer Res. 2022;12(6):2757-2769.
Cho SY, Park JW, Liu Y, Park YS, Kim JH, Yang H, et al. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Gastroenterology. 2017;153(2):536-549.e26. https://doi.org/10.1053/j.gastro.2017.05.012
Carneiro F, Lauwers GY. Epithelial Neoplasms of the Stomach. En: Odze RD, Goldblum JR (editores). Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. 4.a edición. Elsevier; 2022. p. 811-844.e15.
Smyth EC, Fassan M, Cunningham D, Allum WH, Okines AF, Lampis A, et al. Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. J Clin Oncol. 2016;34(23):2721-7. https://doi.org/10.1200/JCO.2015.65.7692
Mahvi D, Fairweather M. Tumors of the Stomach. En: Kellerman RD, Heidelbaugh JJ (editores). Conn’s Current Therapy. Elsevier; 2025 p. 301-305.
Arias Rodríguez FD, Ganchozo Solís RV, Mosquera López ED, Chávez Pasquel DA, Tipán Legarda AI, Álvarez López JK, et al. Cáncer gástrico - actualización en diagnóstico y tratamiento: revisión bibliográfica. Gastroenterol Latinoam. 2024;35(3):151-159. https://doi.org/10.46613/gastrolat2024003-06
Espejo Romero H, Navarrete Siancas J. Clasificación de los adenocarcinomas de estómago. Rev Gastroenterol Peru. 2017;23(3):199-212.
Goldman H, Ming SC. Inflammatory pathology of the intestine. En: Goldman H, Ming SC (editores). Pathology of the gastrointestinal tract. Filadelfia, Estados Unidos: Saunders; 1992. p. 584-617.
Figueiredo C, Camargo MC, Leite M, Fuentes-Pananá EM, Rabkin CS, Machado JC. Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. Curr Top Microbiol Immunol. 2017;400:277-304. https://doi.org/10.1007/978-3-319-50520-6_12
Januszewicz W, Turkot MH, Malfertheiner P, Regula J. A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When? Cancers (Basel). 2023;15(3):664. https://doi.org/10.3390/cancers15030664
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

| Article metrics | |
|---|---|
| Abstract views | 742 |
| Galley views | 519 |
| PDF Views | 519 |
| HTML views | 0 |
| Other views | 0 |














